{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:07:03Z","timestamp":1789103223022,"version":"build-2803163510"},"reference-count":208,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB1060000"],"award-info":[{"award-number":["XDB1060000"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB1260000"],"award-info":[{"award-number":["XDB1260000"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["24430713500"],"award-info":[{"award-number":["24430713500"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23490712700"],"award-info":[{"award-number":["23490712700"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["W2412035"],"award-info":[{"award-number":["W2412035"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32571707"],"award-info":[{"award-number":["32571707"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20328"],"award-info":[{"award-number":["U22A20328"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22474042"],"award-info":[{"award-number":["22474042"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011408","name":"State Key Laboratory of Medicinal Chemical Biology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011408","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.addr.2026.115959","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T14:47:56Z","timestamp":1788706076000},"page":"115959","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Molecular design and delivery of extracellular and membrane protein degradation chimeras"],"prefix":"10.1016","volume":"239","author":[{"given":"Shutong","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijing","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfa","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2026.115959_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103395","article-title":"Protac technology: a new drug design for chemical biology with many challenges in drug discovery","volume":"28","author":"Guedeney","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.addr.2026.115959_bb0010","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1244851","article-title":"Lenalidomide causes selective degradation of Ikzf1 and Ikzf3 in multiple myeloma cells","volume":"343","author":"Kr\u00f6nke","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.addr.2026.115959_bb0015","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/15548627.2020.1718362","article-title":"Targeting selective autophagy by Autac degraders","volume":"16","author":"Takahashi","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.addr.2026.115959_bb0020","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.molcel.2019.09.009","article-title":"Autacs: cargo-specific degraders using selective autophagy","volume":"76","author":"Takahashi","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.addr.2026.115959_bb0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2016.230","article-title":"A comprehensive map of molecular drug targets","volume":"16","author":"Santos","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2026.115959_bb0030","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.addr.2026.115959_bb0035","article-title":"Car-T cell therapy in hematological malignancies: current opportunities and challenges","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2026.115959_bb0040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"Car-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.addr.2026.115959_bb0045","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nbt.1691","article-title":"Antibody recycling by engineered Ph-dependent antigen binding improves the duration of antigen neutralization","volume":"28","author":"Igawa","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2026.115959_bb0050","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41586-020-2545-9","article-title":"Lysosome-targeting chimaeras for degradation of extracellular proteins","volume":"584","author":"Banik","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.addr.2026.115959_bb0055","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1021\/jacs.0c10008","article-title":"Development of antibody-based Protacs for the degradation of the cell-surface immune checkpoint protein Pd-L1","volume":"143","author":"Cotton","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115959_bb0060","doi-asserted-by":"crossref","first-page":"7575","DOI":"10.1038\/s41467-025-62776-w","article-title":"Targeted degradation of cell surface proteins through endocytosis triggered by cell-penetrating peptide-small molecule conjugates","volume":"16","author":"He","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115959_bb0065","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/s41589-024-01803-1","article-title":"Chemically engineered antibodies for autophagy-based receptor degradation","volume":"21","author":"Cheng","year":"2025","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.addr.2026.115959_bb0070","doi-asserted-by":"crossref","DOI":"10.1126\/science.adf6249","article-title":"Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras","volume":"382","author":"Ahn","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.addr.2026.115959_bb0075","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41580-018-0053-7","article-title":"To degrade or not to degrade: mechanisms and significance of endocytic recycling","volume":"19","author":"Cullen","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.addr.2026.115959_bb0080","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrm3332","article-title":"Getting active: protein sorting in endocytic recycling","volume":"13","author":"Victor","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.addr.2026.115959_bb0085","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nrm1050","article-title":"Mannose 6-phosphate Receptors: new twists in the tale","volume":"4","author":"Ghosh","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.addr.2026.115959_bb0090","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ymgme.2012.07.012","article-title":"A shortcut to the lysosome: the mannose-6-phosphate-independent pathway","volume":"107","author":"Coutinho","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.addr.2026.115959_bb0095","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.2174\/092986707782794005","article-title":"Mannose 6-phosphate receptor targeting and its applications in human diseases","volume":"14","author":"Gary-Bobo","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.addr.2026.115959_bb0100","doi-asserted-by":"crossref","first-page":"15172","DOI":"10.1073\/pnas.0607053103","article-title":"Enzyme Therapy in mannose receptor-null Mucopolysaccharidosis vii mice defines roles for the mannose 6-phosphate and mannose Receptors","volume":"103","author":"Sly","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.addr.2026.115959_bb0105","doi-asserted-by":"crossref","first-page":"E2766","DOI":"10.1073\/pnas.1513023113","article-title":"Functional evolution of Igf2:Igf2r domain 11 binding generates novel structural interactions and a specific Igf2 antagonist","volume":"113","author":"Frago","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2026.115959_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202316089","article-title":"Insulin-like growth factor 2-tagged aptamer chimeras (Itacs) modular assembly for targeted and efficient degradation of two membrane proteins","volume":"63","author":"Tian","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115959_bb0115","doi-asserted-by":"crossref","first-page":"11267","DOI":"10.1002\/anie.202102170","article-title":"Bispecific aptamer chimeras enable targeted protein degradation on cell membranes","volume":"60","author":"Miao","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115959_bb0120","doi-asserted-by":"crossref","first-page":"24272","DOI":"10.1021\/jacs.3c08886","article-title":"Insulin-like growth factor 2 (Igf2)-fused lysosomal targeting chimeras for degradation of extracellular and membrane proteins","volume":"145","author":"Zhang","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115959_bb0125","first-page":"24506","article-title":"Covalent Lytac enabled by DNA aptamers for immune checkpoint degradation therapy","volume":"145","author":"Li","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115959_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202417942","article-title":"A bifunctional lysosome-targeting chimera nanoplatform for tumor-selective protein degradation and enhanced cancer immunotherapy","volume":"37","author":"Xing","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2026.115959_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202500311","article-title":"A self-assembling Lytac mediates Ctgf degradation and remodels inflammatory tumor microenvironment for triple-negative breast cancer therapy","volume":"12","author":"Lin","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.addr.2026.115959_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07741-6","article-title":"Lysosomal protease deficiency or substrate overload induces an oxidative-stress mediated Stat3-dependent pathway of lysosomal homeostasis","volume":"9","author":"Mart\u00ednez-F\u00e1bregas","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115959_bb0145","doi-asserted-by":"crossref","first-page":"12157","DOI":"10.1074\/jbc.M113.544973","article-title":"Modulation of mannose and Asialoglycoprotein receptor expression determines glycoprotein hormone half-life at critical points in the reproductive cycle","volume":"289","author":"Mi","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2026.115959_bb0150","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s41589-021-00770-1","article-title":"Lytacs that engage the Asialoglycoprotein receptor for targeted protein degradation","volume":"17","author":"Ahn","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.addr.2026.115959_bb0155","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41589-021-00851-1","article-title":"Bifunctional small molecules that mediate the degradation of extracellular proteins","volume":"17","author":"Caianiello","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.addr.2026.115959_bb0160","article-title":"Catalytic degradation of circulating targets with FcRn-mediated cycling LYTACs","author":"Kougentakis","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.addr.2026.115959_bb0165","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1021\/acscentsci.1c00146","article-title":"Development of Triantennary N-Acetylgalactosamine conjugates as degraders for extracellular proteins","volume":"7","author":"Zhou","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.addr.2026.115959_bb0170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.chembiol.2022.12.003","article-title":"Clearance of plasma Pcsk9 via the asialoglycoprotein receptor mediated by heterobifunctional ligands","volume":"30","author":"Bagdanoff","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.addr.2026.115959_bb0175","doi-asserted-by":"crossref","first-page":"2300288","DOI":"10.1002\/advs.202300288","article-title":"Nano-Lytacs for degradation of membrane proteins and inhibition of Cd24\/Siglec-10 signaling pathway","volume":"10","author":"Wang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.addr.2026.115959_bb0180","article-title":"A Heparanase-specific Lytac degrader reinforces natural killer cell cytotoxicity within the tumor microenvironment","volume":"5","author":"Li","year":"2024","journal-title":"Cell Rep. Phys. Sci."},{"key":"10.1016\/j.addr.2026.115959_bb0185","doi-asserted-by":"crossref","first-page":"44162","DOI":"10.1021\/jacs.5c13607","article-title":"Bifunctional Lytac mediates hepatocytes-hepatic stellate cells crosstalk by regulating 5-Ht2a receptor degradation and antagonism to synergistically ameliorate hepatic fibrosis","volume":"147","author":"Zhou","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115959_bb0190","doi-asserted-by":"crossref","first-page":"24895","DOI":"10.1021\/acsnano.5c03556","article-title":"Tetrahedral deoxyribonucleic acid-engineered multivalent lysosome-targeting chimera for enhanced and dual membrane protein degradation","volume":"19","author":"Zhu","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115959_bb0195","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.chempr.2023.06.003","article-title":"Biomarker-activated multifunctional lysosome-targeting chimeras mediated selective degradation of extracellular amyloid fibrils","volume":"9","author":"Liu","year":"2023","journal-title":"Chem"},{"key":"10.1016\/j.addr.2026.115959_bb0200","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","article-title":"Rage and amyloid-\u0392 peptide neurotoxicity in Alzheimer's disease","volume":"382","author":"Shi Du","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.addr.2026.115959_bb0205","doi-asserted-by":"crossref","first-page":"21730","DOI":"10.1021\/jacs.0c09390","article-title":"Targeting microglia for Therapy of Parkinson's disease by using biomimetic Ultrasmall nanoparticles","volume":"142","author":"Liu","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115959_bb0210","doi-asserted-by":"crossref","first-page":"8141","DOI":"10.1021\/acsnano.2c11476","article-title":"Enantioselective degrader for elimination of extracellular aggregation-prone proteins Hiapp associated with type 2 diabetes","volume":"17","author":"Liu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115959_bb0215","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.cell.2016.10.056","article-title":"Structural mechanism for cargo recognition by the retromer complex","volume":"167","author":"Lucas","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.addr.2026.115959_bb0220","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1158\/1078-0432.CCR-09-0343","article-title":"Targeting Nedd8-activated Cullin-ring ligases for the treatment of Cancer","volume":"15","author":"Soucy","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2026.115959_bb0225","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ncb1301","article-title":"Neddylation and Deneddylation regulate Cul1 and Cul3 protein accumulation","volume":"7","author":"June-Tai","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.addr.2026.115959_bb0230","doi-asserted-by":"crossref","DOI":"10.1126\/science.abn5637","article-title":"Lysosomal enzyme trafficking factor Lyset enables nutritional usage of extracellular proteins","volume":"378","author":"Pechincha","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.addr.2026.115959_bb0235","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.freeradbiomed.2018.06.037","article-title":"Transferrin and transferrin Receptors update","volume":"133","author":"Kawabata","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.addr.2026.115959_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.607692","article-title":"Antibodies targeting the transferrin receptor 1 (Tfr1) as direct anti-Cancer agents","volume":"12","author":"Candelaria","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2026.115959_bb0245","doi-asserted-by":"crossref","first-page":"9108","DOI":"10.1016\/S0021-9258(17)44637-0","article-title":"The kinetics of transferrin endocytosis and Iron uptake from transferrin in rabbit reticulocytes","volume":"258","author":"Iacopetta","year":"1983","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2026.115959_bb0250","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41586-024-07947-3","article-title":"Transferrin receptor targeting chimeras for membrane protein degradation","volume":"638","author":"Zhang","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.addr.2026.115959_bb0255","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/s41467-025-56648-6","article-title":"A covalent peptide-based lysosome-targeting protein degradation platform for Cancer immunotherapy","volume":"16","author":"Xiao","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115959_bb0260","doi-asserted-by":"crossref","first-page":"6864","DOI":"10.1021\/acs.nanolett.4c06279","article-title":"Smartphone-manipulated mild-temperature photothermal control of the Tfr-Lytac platform for tumor treatment","volume":"25","author":"Shi","year":"2025","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2026.115959_bb0265","doi-asserted-by":"crossref","first-page":"8731","DOI":"10.1038\/s41467-024-52975-2","article-title":"Cypher: catalytic extracellular targeted protein degradation with high potency and durable effect","volume":"15","author":"Crook","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115959_bb0270","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.addr.2004.01.010","article-title":"Folate receptor endocytosis and Trafficking","volume":"56","author":"Sabharanjak","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2026.115959_bb0275","doi-asserted-by":"crossref","first-page":"8695","DOI":"10.1038\/s41467-024-52685-9","article-title":"Development of folate receptor targeting chimeras for Cancer selective degradation of extracellular proteins","volume":"15","author":"Zhou","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115959_bb0280","doi-asserted-by":"crossref","first-page":"8804","DOI":"10.1038\/s41467-025-63882-5","article-title":"Dual membrane receptor degradation via folate receptor targeting chimera","volume":"16","author":"Wang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115959_bb0285","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biocel.2015.11.014","article-title":"Niclosamide inhibits epithelial-mesenchymal transition and tumor growth in Lapatinib-resistant human epidermal growth factor receptor 2-positive breast Cancer","volume":"71","author":"Liu","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.addr.2026.115959_bb0290","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1907059","article-title":"Vista and Pd-L1 synergistically predict poor prognosis in patients with extranodal natural killer\/T-cell lymphoma","volume":"10","author":"He","year":"2021","journal-title":"OncoImmunology"},{"key":"10.1016\/j.addr.2026.115959_bb0295","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nature13306","article-title":"Crystal structure of the human glucose transporter Glut1","volume":"510","author":"Dong Deng","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.addr.2026.115959_bb0300","article-title":"Glut1 promotes cell proliferation via binds and stabilizes phosphorylated Egfr in lung adenocarcinoma","volume":"22","author":"Zhiqing","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.addr.2026.115959_bb0305","doi-asserted-by":"crossref","first-page":"17728","DOI":"10.1021\/jacs.4c02463","article-title":"Lysosome targeting chimaeras for Glut1-facilitated targeted protein degradation","volume":"146","author":"Luo","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115959_bb0310","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1126\/science.1078124","article-title":"Structure of the Ldl receptor extracellular domain at endosomal Ph","volume":"298","author":"Rudenko","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.addr.2026.115959_bb0315","doi-asserted-by":"crossref","first-page":"39912","DOI":"10.1021\/jacs.5c15047","article-title":"Hijacking Extracellular Targeted Protein Degrader\u2013Drug Conjugates for Enhanced Drug Delivery","volume":"147","author":"Zhao","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115959_bb0320","doi-asserted-by":"crossref","first-page":"18705","DOI":"10.1021\/jacs.3c05109","article-title":"Targeted lysosomal degradation of secreted and cell surface proteins through the Lrp-1 pathway","volume":"145","author":"Loppinet","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115959_bb0325","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.cell.2026.01.034","article-title":"Efficient amyloid-\u0392 degradation in Alzheimer's disease using Spytacs","volume":"189","author":"Fei Teng","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.addr.2026.115959_bb0330","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrd3777","article-title":"G protein-coupled receptors for energy metabolites as new therapeutic targets","volume":"11","author":"Blad","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2026.115959_bb0335","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s42255-020-0171-3","article-title":"Targeted pharmacological therapy restores \u0392-cell function for diabetes remission","volume":"2","author":"Sachs","year":"2020","journal-title":"Nat. Metab."},{"key":"10.1016\/j.addr.2026.115959_bb0340","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nature22378","article-title":"Human Glp-1 receptor transmembrane domain structure in complex with allosteric modulators","volume":"546","author":"Song","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.addr.2026.115959_bb0345","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.mce.2013.11.010","article-title":"Real-time trafficking and signaling of the glucagon-like peptide-1 receptor","volume":"382","author":"Roed","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.addr.2026.115959_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106908","article-title":"Conjugation with glucagon like Peptide-1 enables targeted protein degradation","volume":"141","author":"Zhu","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.addr.2026.115959_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118473","article-title":"Development of glucagon-like Peptide-1 lysosomal targeting chimeras for degradation of extracellular and membrane proteins","volume":"303","author":"Zhu","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.addr.2026.115959_bb0360","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/cmi.2017.107","article-title":"The unique structural and functional features of Cxcl12","volume":"15","author":"Janssens","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.addr.2026.115959_bb0365","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41587-022-01456-2","article-title":"Modular cytokine receptor-targeting chimeras for targeted degradation of cell surface and extracellular proteins","volume":"41","author":"Pance","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2026.115959_bb0370","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2524129123","article-title":"A cytokine receptor\u2013targeting chimera toolbox for expanding extracellular targeted protein degradation","volume":"123","author":"Kumru","year":"2026","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2026.115959_bb0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2010.04.006","article-title":"Chemokine receptors intracellular trafficking","volume":"127","author":"Borroni","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.addr.2026.115959_bb0380","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41573-022-00557-6","article-title":"Emerging principles of cytokine pharmacology and therapeutics","volume":"22","author":"Saxton","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2026.115959_bb0385","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","article-title":"Integrins: bidirectional, allosteric signaling machines","volume":"110","author":"Hynes","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.addr.2026.115959_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104100","article-title":"177lu-labeled cyclic Rgd peptide as an imaging and targeted radionuclide therapeutic agent in non-small cell lung cancer: biological evaluation and preclinical study","volume":"102","author":"Pirooznia","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.addr.2026.115959_bb0395","doi-asserted-by":"crossref","first-page":"21831","DOI":"10.1021\/jacs.2c08367","article-title":"Bifunctional compounds as molecular degraders for integrin-facilitated targeted protein degradation","volume":"144","author":"Zheng","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115959_bb0400","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300643","article-title":"Development of integrin targeting chimeras (Itacs) for the lysosomal degradation of extracellular proteins","volume":"19","author":"Zhou","year":"2024","journal-title":"ChemMedChem"},{"key":"10.1016\/j.addr.2026.115959_bb0405","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1021\/acs.nanolett.5c00341","article-title":"Multivalent Rgd peptide-mediated Nanochimera for lysosomal degradation of Pdl1 protein","volume":"25","author":"Song","year":"2025","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2026.115959_bb0410","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/s41467-024-46130-0","article-title":"A co-assembly platform engaging macrophage scavenger receptor a for lysosome-targeting protein degradation","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115959_bb0415","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.chembiol.2021.04.002","article-title":"An E3 ligase guide to the galaxy of small-molecule-induced protein degradation","volume":"28","author":"Jevti\u0107","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.addr.2026.115959_bb0420","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3390\/membranes1040354","article-title":"The role of the transmembrane ring finger proteins in cellular and organelle function","volume":"1","author":"Nakamura","year":"2011","journal-title":"Membranes"},{"key":"10.1016\/j.addr.2026.115959_bb0425","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3787","article-title":"Structural and molecular basis of Znrf3\/Rnf43 transmembrane ubiquitin ligase inhibition by the Wnt agonist R-Spondin","volume":"4","author":"Zebisch","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115959_bb0430","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41586-022-05235-6","article-title":"Antibody targeting of E3 ubiquitin ligases for receptor degradation","volume":"610","author":"Marei","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.addr.2026.115959_bb0435","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nature11019","article-title":"Znrf3 promotes Wnt receptor turnover in an R-Spondin-sensitive manner","volume":"485","author":"Hao","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.addr.2026.115959_bb0440","first-page":"739","article-title":"Rotacs leverage signaling-incompetent R-Spondin for targeted protein degradation, cell","volume":"30","author":"Sun","year":"2023","journal-title":"Chem. Biol."},{"key":"10.1016\/j.addr.2026.115959_bb0445","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1021\/acssynbio.2c00587","article-title":"Receptor elimination by E3 ubiquitin ligase recruitment (Reulr): a targeted protein degradation toolbox","volume":"12","author":"Siepe","year":"2023","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.addr.2026.115959_bb0450","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202501488","article-title":"Structure-guided development of chemically tailored peptide binders of Rnf43\/Znrf3 to enable versatile design of membrane protein-targeting Protacs","volume":"64","author":"Cui","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115959_bb0455","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with Alphafold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.addr.2026.115959_bb0460","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.chembiol.2017.09.009","article-title":"The advantages of targeted protein degradation over inhibition: an RTK case study","volume":"25","author":"Burslem","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.addr.2026.115959_bb0465","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1021\/acs.jmedchem.9b01566","article-title":"Discovery of potent and selective epidermal growth factor receptor (EGFR) bifunctional small-molecule degraders","volume":"63","author":"Cheng","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.addr.2026.115959_bb0470","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202501857","article-title":"Membrane-bounded intracellular E3 ubiquitin ligase-targeting chimeras (Membtacs) for targeted membrane protein degradation","volume":"64","author":"Mo","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115959_bb0475","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature13905","article-title":"Microrna silencing for Cancer Therapy targeted to the tumour microenvironment","volume":"518","author":"Cheng","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.addr.2026.115959_bb0480","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/15548627.2024.2439657","article-title":"Baicalein tethers Cd274\/Pd-L1 for autophagic degradation to boost antitumor immunity","volume":"21","author":"Hao","year":"2025","journal-title":"Autophagy"},{"key":"10.1016\/j.addr.2026.115959_bb0485","article-title":"The Autotac chemical biology platform for targeted protein degradation via the autophagy-lysosome system","volume":"13","author":"Ji","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115959_bb0490","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1021\/mp500111u","article-title":"Autophagy-related gene expression analysis of wild-type and Atg5 gene knockout mouse embryonic fibroblast cells treated with Polyethylenimine","volume":"11","author":"Lin","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2026.115959_bb0495","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41580-022-00542-2","article-title":"The mechanisms and roles of selective autophagy in mammals","volume":"24","author":"Vargas","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.addr.2026.115959_bb0500","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-67805-2","article-title":"Endosome-phagophore linking assemblies for the degradation of membrane\/extracellular proteins","volume":"16","author":"Wang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115959_bb0505","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pharmthera.2015.07.003","article-title":"Flynn, cell-penetrating peptides transport therapeutics into cells","volume":"154","author":"Joshua","year":"2015","journal-title":"Pharmacol. & Therapeutics"},{"key":"10.1016\/j.addr.2026.115959_bb0510","doi-asserted-by":"crossref","first-page":"25371","DOI":"10.1021\/jacs.4c10533","article-title":"Cell-penetrating peptides translocate across the plasma membrane by inducing vesicle budding and collapse","volume":"146","author":"Sahni","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115959_bb0515","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3390\/pharmaceutics14050907","article-title":"Redesigning of cell-penetrating peptides to improve their efficacy as a drug delivery system","volume":"14","author":"Szab\u00f3","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2026.115959_bb0520","doi-asserted-by":"crossref","first-page":"32933","DOI":"10.1021\/jacs.4c06160","article-title":"Conditionally activatable chimeras for tumor-specific membrane protein degradation","volume":"146","author":"Liu","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115959_bb0525","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41589-018-0161-x","article-title":"Hip1r targets PD-L1 to lysosomal degradation to alter T cell\u2013mediated cytotoxicity","volume":"15","author":"Wang","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.addr.2026.115959_bb0530","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nn.3637","article-title":"Rapid and reversible knockdown of endogenous proteins by peptide-directed lysosomal degradation","volume":"17","author":"Fan","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.addr.2026.115959_bb0535","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.copbio.2010.08.007","article-title":"Small peptide recognition sequence for intracellular sorting","volume":"21","author":"Pandey","year":"2010","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.addr.2026.115959_bb0540","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1039\/D0OB00265H","article-title":"Protein labeling approach to improve lysosomal targeting and efficacy of antibody\u2013drug conjugates","volume":"18","author":"Han","year":"2020","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.addr.2026.115959_bb0545","doi-asserted-by":"crossref","first-page":"15807","DOI":"10.1021\/acs.jmedchem.4c01449","article-title":"Peptide-mediated small molecule lysosome-targeting chimeras for targeted degradation of membrane and intracellular proteins","volume":"67","author":"Chen","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.addr.2026.115959_bb0550","doi-asserted-by":"crossref","first-page":"19107","DOI":"10.1021\/jacs.3c07687","article-title":"Harnessing the lysosomal sorting signals of the cation-independent mannose-6-phosphate receptor for targeted degradation of membrane proteins","volume":"145","author":"Yu","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115959_bb0555","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bbamcr.2008.10.016","article-title":"Sorting of lysosomal proteins","volume":"1793","author":"Braulke","year":"2009","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"10.1016\/j.addr.2026.115959_bb0560","doi-asserted-by":"crossref","first-page":"17652","DOI":"10.1039\/D4SC05093B","article-title":"Lysosome\u2013targeting chimeras containing an endocytic signaling motif trigger endocytosis and lysosomal degradation of cell-surface proteins","volume":"15","author":"Fang","year":"2024","journal-title":"Chem. Sci."},{"key":"10.1016\/j.addr.2026.115959_bb0565","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41586-024-07948-2","article-title":"Designed endocytosis-inducing proteins degrade targets and amplify signals","volume":"638","author":"Huang","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.addr.2026.115959_bb0570","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202501222","article-title":"Sortilin-mediated rapid, precise and sustained degradation of membrane proteins via Mrna-encoded lysosome-targeting chimera","volume":"12","author":"Chang","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.addr.2026.115959_bb0575","doi-asserted-by":"crossref","first-page":"7998","DOI":"10.1038\/s41467-024-52396-1","article-title":"Clearance and transport of amyloid \u0392 by peripheral monocytes correlate with Alzheimer's disease progression","volume":"15","author":"Huang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115959_bb0580","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/s41551-025-01525-2","article-title":"Targeted clearance of extracellular tau using aptamer-armed monocytes alleviates neuroinflammation in mice with Alzheimer's disease","volume":"10","author":"Zhuo","year":"2026","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.addr.2026.115959_bb0585","doi-asserted-by":"crossref","first-page":"36301","DOI":"10.1021\/jacs.5c09630","article-title":"Cell-selective targeting chimeras (Selectacb) for membrane protein degradation on B cells","volume":"147","author":"Yang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115959_bb0590","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri3070","article-title":"Monocyte recruitment during infection and inflammation","volume":"11","author":"Shi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2026.115959_bb0595","doi-asserted-by":"crossref","first-page":"R790","DOI":"10.1016\/j.cub.2020.05.051","article-title":"Scavenger receptors","volume":"30","author":"Alquraini","year":"2020","journal-title":"Curr. Biol."},{"key":"10.1016\/j.addr.2026.115959_bb0600","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1021\/acs.molpharmaceut.0c00562","article-title":"Application of a scavenger receptor A1-targeted polymeric prodrug platform for lymphatic drug delivery in Hiv","volume":"17","author":"Stevens","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2026.115959_bb0605","article-title":"Fine tuning the properties of stapled peptides by stereogenic \u0391-amino acid bridges","volume":"29","author":"Wang","year":"2023","journal-title":"Chemistry (Weinheim an der Bergstrasse, Germany)"},{"key":"10.1016\/j.addr.2026.115959_bb0610","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s40259-014-0098-x","article-title":"The role of interleukin-17a in psoriatic disease","volume":"28","author":"Adami","year":"2014","journal-title":"BioDrugs"},{"key":"10.1016\/j.addr.2026.115959_bb0615","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1172\/JCI27179","article-title":"Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation","volume":"116","author":"Stratis","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2026.115959_bb0620","first-page":"e292","article-title":"Rationale for Cd40 pathway blockade in autoimmune rheumatic disorders, the lancet","volume":"2","author":"Pucino","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.addr.2026.115959_bb0625","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202511467","article-title":"Hertacs enable tumor-selective lysosomal degradation of membrane and extracellular proteins via Her2 Trafficking","volume":"64","author":"He","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115959_bb0630","doi-asserted-by":"crossref","first-page":"26218","DOI":"10.1021\/acs.jmedchem.5c02262","article-title":"Degrader-drug conjugate (Ddc) mediated Immunochemotherapy for tumor treatment","volume":"68","author":"Chen","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.addr.2026.115959_bb0635","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41589-018-0021-8","article-title":"The Dtag system for immediate and target-specific protein degradation","volume":"14","author":"Nabet","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.addr.2026.115959_bb0640","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.chembiol.2020.04.003","article-title":"Targeted degradation of Slc transporters reveals amenability of multi-pass transmembrane proteins to ligand-induced proteolysis","volume":"27","author":"Bensimon","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.addr.2026.115959_bb0645","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.chembiol.2022.08.004","article-title":"Target protein localization and its impact on Protac-mediated degradation","volume":"29","author":"Simpson","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.addr.2026.115959_bb0650","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.tcb.2025.01.002","article-title":"Endoplasmic reticulum (Er) protein degradation by Er-associated degradation and Er-phagy","volume":"35","author":"Wu","year":"2025","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.addr.2026.115959_bb0655","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.cell.2026.01.018","article-title":"Hijacking Erad for targeted degradation of transmembrane proteins","volume":"189","author":"Song","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.addr.2026.115959_bb0660","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1038\/s41467-025-66382-8","article-title":"Chemically-induced degradation of the endoplasmic-reticulum stress sensor Ire1 by a Vhl-recruiting chimera","volume":"16","author":"Jin","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115959_bb0665","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1021\/acschembio.2c00185","article-title":"Roadmap for optimizing and broadening antibody-based Protacs for degradation of cell surface proteins","volume":"17","author":"Gramespacher","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.addr.2026.115959_bb0670","article-title":"De novo Design of Structure-Tunable Multivalent Targeting Chimeras for tumor-targeted Pd-L1 degradation and potentiated Cancer immunotherapy","volume":"64","author":"Zhou","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115959_bb0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.108482","article-title":"Bifunctional compounds for targeted degradation of carbonic anhydrase IX through integrin-facilitated lysosome degradation","volume":"301","author":"He","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2026.115959_bb0680","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1021\/acschembio.3c00229","article-title":"Synthetic site-specific antibody\u2013ligand conjugates promote asialoglycoprotein receptor-mediated degradation of extracellular human Pcsk9","volume":"18","author":"Donahue","year":"2023","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.addr.2026.115959_bb0685","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/s41573-024-01051-x","article-title":"Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics","volume":"23","author":"Carter","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2026.115959_bb0690","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1021\/acsmacrolett.6b00297","article-title":"Controlled synthesis of end-functionalized mannose-6-phosphate glycopolypeptides for lysosome targeting","volume":"5","author":"Das","year":"2016","journal-title":"ACS Macro Lett."},{"key":"10.1016\/j.addr.2026.115959_bb0695","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4161\/mabs.2.3.11641","article-title":"The immunogenicity of humanized and fully human antibodies","volume":"2","author":"Harding","year":"2010","journal-title":"mAbs"},{"key":"10.1016\/j.addr.2026.115959_bb0700","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1021\/ar7000815","article-title":"Discovery and development of folic-acid-based receptor targeting for imaging and Therapy of Cancer and inflammatory diseases","volume":"41","author":"Low","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.addr.2026.115959_bb0705","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1021\/mp3002733","article-title":"Rgd-based strategies to target alpha(V) Beta(3) integrin in Cancer Therapy and diagnosis","volume":"9","author":"Danhier","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2026.115959_bb0710","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1158\/0008-5472.CAN-06-2480","article-title":"A peptide conjugate of vitamin E succinate targets breast Cancer cells with high Erbb2 expression","volume":"67","author":"Wang","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2026.115959_bb0715","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1039\/C8CS00960K","article-title":"The growing applications of Sufex click Chemistry","volume":"48","author":"Barrow","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.addr.2026.115959_bb0720","doi-asserted-by":"crossref","first-page":"12471","DOI":"10.1021\/acs.chemrev.3c00377","article-title":"Aptamer\u2013protein interactions: From regulation to biomolecular detection","volume":"123","author":"Ji","year":"2023","journal-title":"Chem. Rev."},{"key":"10.1016\/j.addr.2026.115959_bb0725","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.addr.2018.08.005","article-title":"Aptamer-based targeted therapy","volume":"134","author":"Zhu","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2026.115959_bb0730","doi-asserted-by":"crossref","first-page":"25490","DOI":"10.1021\/jacs.4c04794","article-title":"Development of integrin-facilitated bispecific aptamer chimeras for membrane protein degradation","volume":"146","author":"Sun","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115959_bb0735","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ccell.2022.06.011","article-title":"Oncogenic collagen I homotrimers from cancer cells bind to \u03913\u03b21 integrin and impact tumor microbiome and immunity to promote pancreatic cancer","volume":"40","author":"Chen","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.addr.2026.115959_bb0740","doi-asserted-by":"crossref","first-page":"16958","DOI":"10.1021\/ja505986a","article-title":"Multivalent N-Acetylgalactosamine-conjugated Sirna localizes in hepatocytes and elicits robust Rnai-mediated gene silencing","volume":"136","author":"Nair","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115959_bb0745","article-title":"Aptamer-Lytacs for targeted degradation of extracellular and membrane proteins","volume":"62","author":"Wu","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115959_bb0750","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41586-022-04654-9","article-title":"Design of protein-binding proteins from the target structure alone","volume":"605","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.addr.2026.115959_bb0755","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.abd9909","article-title":"De novo design of picomolar Sars-Cov-2 miniprotein inhibitors","volume":"370","author":"Cao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.addr.2026.115959_bb0760","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.add2187","article-title":"Robust deep learning\u2013based protein sequence design using Proteinmpnn","volume":"378","author":"Dauparas","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.addr.2026.115959_bb0765","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.tins.2012.01.003","article-title":"Sortilin: a receptor to regulate neuronal viability and function","volume":"35","author":"Nykjaer","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.addr.2026.115959_bb0770","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/med.10008","article-title":"Transferrin\/transferrin receptor-mediated drug delivery","volume":"22","author":"Li","year":"2002","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.addr.2026.115959_bb0775","doi-asserted-by":"crossref","first-page":"17615","DOI":"10.1073\/pnas.0906541106","article-title":"Endosomes: a legitimate platform for the signaling train","volume":"106","author":"Murphy","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.addr.2026.115959_bb0780","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with Alphafold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.addr.2026.115959_bb0785","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cell.2020.05.028","article-title":"Developing covalent protein drugs via proximity-enabled reactive therapeutics","volume":"182","author":"Li","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.addr.2026.115959_bb0790","doi-asserted-by":"crossref","DOI":"10.1038\/s43586-021-00028-z","article-title":"Bioorthogonal chemistry","volume":"1","author":"Scinto","year":"2021","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.addr.2026.115959_bb0795","doi-asserted-by":"crossref","first-page":"16377","DOI":"10.1021\/jacs.1c08521","article-title":"Covalently engineered nanobody chimeras for targeted membrane protein degradation","volume":"143","author":"Zhang","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115959_bb0800","doi-asserted-by":"crossref","first-page":"31899","DOI":"10.1038\/srep31899","article-title":"Improved variants of Srta for site-specific conjugation on antibodies and proteins with high efficiency","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2026.115959_bb0805","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41586-025-09903-1","article-title":"Intratumoural vaccination via checkpoint degradation-coupled antigen presentation","volume":"650","author":"Han","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.addr.2026.115959_bb0810","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adq3940","article-title":"Tumor-specific delivery of clickable inhibitor for Pd-L1 degradation and mitigating resistance of radioimmunotherapy","volume":"10","author":"Hou","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.addr.2026.115959_bb0815","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s41557-020-00587-w","article-title":"Metabolic glycan labelling for Cancer-targeted Therapy","volume":"12","author":"Wang","year":"2020","journal-title":"Nat. Chem."},{"key":"10.1016\/j.addr.2026.115959_bb0820","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nature02791","article-title":"Chemical Remodelling of cell surfaces in living animals","volume":"430","author":"Prescher","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.addr.2026.115959_bb0825","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/imr.12392","article-title":"Sweeping antibody as a novel therapeutic antibody modality capable of eliminating soluble antigens from circulation","volume":"270","author":"Igawa","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.addr.2026.115959_bb0830","article-title":"Engineered bioorthogonal poly-Protac nanoparticles for tumour-specific protein degradation and precise cancer therapy","volume":"13","author":"Gao","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115959_bb0835","doi-asserted-by":"crossref","first-page":"10963","DOI":"10.1073\/pnas.1105351108","article-title":"Designing super selectivity in multivalent nano-particle binding","volume":"108","author":"Martinez-Veracoechea","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2026.115959_bb0840","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1021\/jacs.8b12553","article-title":"Multivalent recognition at fluid surfaces: the interplay of receptor clustering and superselectivity","volume":"141","author":"Dubacheva","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115959_bb0845","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jconrel.2019.12.049","article-title":"Multivalent Her2-binding polymer conjugates facilitate rapid endocytosis and enhance intracellular drug delivery","volume":"319","author":"Radford","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115959_bb0850","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1021\/acs.nanolett.7b02031","article-title":"Acidity-triggered ligand-presenting nanoparticles to overcome sequential drug delivery barriers to tumors","volume":"17","author":"Wang","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2026.115959_bb0855","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/s41589-025-01924-1","article-title":"Polyvalent folate receptor-targeting chimeras for degradation of membrane proteins","volume":"21","author":"Xiao","year":"2025","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.addr.2026.115959_bb0860","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202407986","article-title":"Programmable circular multivalent Nanobody-targeting chimeras (Mnbtacs) for multireceptor-mediated protein degradation and targeted drug delivery","volume":"63","author":"Jiang","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115959_bb0865","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1021\/jacs.5c17519","article-title":"Polymeric lysosome-targeting chimeras (Polytacs): extracellular targeted protein degradation without co-opting lysosome-targeting receptors","volume":"148","author":"Lu","year":"2026","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115959_bb0870","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41573-022-00615-z","article-title":"Rational combinations of targeted Cancer therapies: background, advances and challenges","volume":"22","author":"Jin","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2026.115959_bb0875","doi-asserted-by":"crossref","first-page":"6608","DOI":"10.1038\/s41467-024-50735-w","article-title":"A region-confined Protac nanoplatform for spatiotemporally tunable protein degradation and enhanced cancer therapy","volume":"15","author":"Gao","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115959_bb0880","first-page":"42221","article-title":"Ultrasound-Activatable lipid nanoplatform for region-confined innate immune stimulation and Mrna vaccination therapy of cancer","volume":"147","author":"Chen","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115959_bb0885","doi-asserted-by":"crossref","first-page":"22412","DOI":"10.1021\/jacs.5c00124","article-title":"Engineering of Sono-Activatable immunogels for immunometabolism disorder normalization therapy of breast cancer","volume":"147","author":"Guo","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115959_bb0890","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1021\/jacs.5c16311","article-title":"In situ transformable photothermal targeting chimeras for spatiotemporally controllable protein degradation and combination immunotherapy for cancer","volume":"148","author":"Dang","year":"2026","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115959_bb0895","doi-asserted-by":"crossref","first-page":"20989","DOI":"10.1021\/jacs.5c05456","article-title":"Phototriggered Lytac: photoactive bispecific aptamer chimera enhances targeted degradation of membrane protein through regulating cell autophagy","volume":"147","author":"Zhang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115959_bb0900","doi-asserted-by":"crossref","first-page":"34669","DOI":"10.1021\/jacs.4c13022","article-title":"Sonodynamic Nano-Lytacs Reverse tumor immunosuppressive microenvironment for cancer immunotherapy","volume":"146","author":"Xu","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115959_bb0905","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.chembiol.2024.01.002","article-title":"Anti-tumor immunotherapy using engineered bacterial outer membrane vesicles fused to lysosome-targeting chimeras mediated by transferrin receptor","volume":"31","author":"Su","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.addr.2026.115959_bb0910","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ymthe.2024.11.034","article-title":"Engineered extracellular vesicles as nanosponges for lysosomal degradation of PCSK9","volume":"33","author":"Wang","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2026.115959_bb0915","doi-asserted-by":"crossref","first-page":"25004","DOI":"10.1021\/jacs.5c08368","article-title":"Delivery of peptide-Lytac via Polyporus polysaccharide microneedles for targeted Cd47 degradation and enhanced tumor immunotherapy","volume":"147","author":"Lin","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115959_bb0920","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jconrel.2023.08.019","article-title":"Polysaccharide-based tumor microenvironment-responsive drug delivery systems for cancer therapy","volume":"362","author":"Wu","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115959_bb0925","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jconrel.2023.07.039","article-title":"Targeting endothelial permeability in the EPR effect","volume":"361","author":"Lahooti","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115959_bb0930","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1039\/D0CS01127D","article-title":"Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine","volume":"50","author":"de Almeida","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.addr.2026.115959_bb0935","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.101119","article-title":"Advances in lysosomal escape mechanisms for gynecological Cancer Nano-Therapeutics","volume":"14","author":"Wei","year":"2024","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.addr.2026.115959_bb0940","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41565-024-01801-3","article-title":"Targeted protein degradation via cellular Trafficking of nanoparticles","volume":"20","author":"Liu","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2026.115959_bb0945","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.drudis.2021.12.007","article-title":"Multicompartment systems: a putative carrier for combined drug delivery and targeting","volume":"27","author":"Gautam","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.addr.2026.115959_bb0950","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.1038\/s41467-024-51720-z","article-title":"A plug-and-play monofunctional platform for targeted degradation of extracellular proteins and vesicles","volume":"15","author":"Yao","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115959_bb0955","doi-asserted-by":"crossref","first-page":"2420004","DOI":"10.1002\/adfm.202420004","article-title":"A plug-and-play Ferritac platform degrading membrane proteins via receptor crosslinking","volume":"35","author":"He","year":"2025","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.addr.2026.115959_bb0960","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202507608","article-title":"Engineered virus-like nanoparticles enable multimodal protein degradation for enhanced tumor Therapy","volume":"37","author":"Dou","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2026.115959_bb0965","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1038\/s41587-024-02494-8","article-title":"Engineered platelets as targeted protein degraders and application to breast cancer models","volume":"43","author":"Chen","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2026.115959_bb0970","doi-asserted-by":"crossref","first-page":"12641","DOI":"10.1021\/acs.jmedchem.5c00379","article-title":"Extracellular Hsp90-facilitated degradation of extracellular and membrane proteins by bifunctional small molecules","volume":"68","author":"Zhang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.addr.2026.115959_bb0975","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000206715","article-title":"Novel bispecific degrader Bhv-1300 achieves rapid, robust, and selective IgG reduction in preclinical models including nonhuman primates (S43.004)","volume":"102","author":"Bunin","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.addr.2026.115959_bb0980","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/d41573-024-00103-6","article-title":"Extracellular targeted protein degrader removes antibodies in first test in humans","volume":"23","author":"Mullard","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2026.115959_bb0985","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1212\/WNL.0000000000216812","article-title":"A novel mechanism for the treatment of autoimmune neurologic diseases: robust, Rapid, and tunable removal of igg with the mode\u2122 degrader Bhv-1300 (P5-2.004)","volume":"106","author":"Awsare","year":"2026","journal-title":"Neurology"},{"key":"10.1016\/j.addr.2026.115959_bb0990","author":"Avilar Therapeutics"},{"key":"10.1016\/j.addr.2026.115959_bb0995","series-title":"Targeted Plasma Protein Degradation","author":"Martin","year":"2021"},{"key":"10.1016\/j.addr.2026.115959_bb1000","series-title":"Degradation of Extracellular Targets","author":"Martin","year":"2022"},{"key":"10.1016\/j.addr.2026.115959_bb1005","doi-asserted-by":"crossref","DOI":"10.1002\/advs.75658","article-title":"A plug-and-play platform for customizing multivalent degraders and degrader-drug conjugates","volume":"13","author":"Zhao","year":"2026","journal-title":"Adv. Sci."},{"key":"10.1016\/j.addr.2026.115959_bb1010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41571-023-00850-2","article-title":"Exploring the next generation of antibody\u2013drug conjugates","volume":"21","author":"Tsuchikama","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.addr.2026.115959_bb1015","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41573-023-00709-2","article-title":"Antibody\u2013drug conjugates come of age in oncology","volume":"22","author":"Dumontet","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2026.115959_bb1020","series-title":"clinical pharmacology considerations for antibody-drug conjugates: Guidance for industry","author":"U. S. Food, Administration drug","year":"2024"},{"key":"10.1016\/j.addr.2026.115959_bb1025","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nm.2609","article-title":"Identification of a mutation in the extracellular domain of the epidermal growth factor receptor conferring Cetuximab resistance in colorectal Cancer","volume":"18","author":"Montagut","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2026.115959_bb1030","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1158\/1078-0432.CCR-16-0970","article-title":"Tnf\u03b1-induced mucin 4 expression elicits Trastuzumab resistance in Her2-positive breast Cancer","volume":"23","author":"Mercogliano","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2026.115959_bb1035","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13046-024-03143-3","article-title":"The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in Her2-targeted antibody\u2013drug conjugate\u2013resistant Her2-overexpressing breast cancer","volume":"43","author":"Lee","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.addr.2026.115959_bb1040","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-32159-6","article-title":"Structure-guided and phage-assisted evolution of a therapeutic anti-Egfr antibody to reverse acquired resistance","volume":"13","author":"Zhuang","year":"2022","journal-title":"Nat. Commun."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X26001936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X26001936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:30:37Z","timestamp":1789101037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X26001936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":208,"alternative-id":["S0169409X26001936"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2026.115959","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular design and delivery of extracellular and membrane protein degradation chimeras","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2026.115959","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115959"}}